Heron Therapeutics | HRTX - EPS Earnings Per Share


Heron Therapeutics reported $-0.03 in EPS Earnings Per Share for its fiscal quarter ending in September of 2024.





Eps Change Date
ALKERMES USD 0.29 0.2 Dec/2025
Alnylam Pharmaceuticals USD 1.25 1.65 Dec/2025
Amarin USD 0.08 0.11 Sep/2025
ANI Pharmaceuticals USD 2.33 0.29 Dec/2025
Anika Therapeutics USD -0.34 1.16 Mar/2025
Arrowhead Research USD 0.22 0.33 Dec/2025
Eisai JPY 60.94 24.92 Dec/2025
Emergent BioSolutions USD -0.77 0.29 Dec/2023
Esperion Therapeutics USD -0.15 0.18 Sep/2024
GlaxoSmithKline GBP 0.26 0.29 Dec/2025
Heron Therapeutics USD -0.03 0.03 Sep/2024
Insmed USD -1.54 0.21 Dec/2025
Ligand Pharmaceuticals USD 2.02 1.07 Dec/2025
Merck USD 2.04 0.54 Dec/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Neurocrine Biosciences USD 1.88 0.29 Dec/2025
Omeros USD -1.12 0.37 Jun/2024
Pacira USD 0.06 0.64 Dec/2025
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Roche Holding CHF 8.37 2.95 Dec/2025
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Surmodics USD -0.25 0.28 Sep/2024
Ultragenyx Pharmaceutical USD -1.29 0.52 Dec/2025
Veracyte USD 0.53 0.02 Dec/2025
Vertex Pharmaceuticals USD 5.03 0.23 Dec/2025